Episode 43: Hot Topics Mini-Series: Stem Cell Therapy in Multiple Sclerosis
Stanford Medcast: Expert Voices in Medicine and Healthcare · Stanford Medcast
Audio is streamed directly from the publisher (op3.dev) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Today's episode includes a discussion with Dr. Jeffrey Dunn who serves as the Lily Sarafan Director of Neuroimmunology, Clinical Professor and Chief of Neuroimmunology within the Department of Neurology & Neurological Sciences at Stanford University. The discussion includes an overview of the different types of stem cells, as it relates to Multiple Sclerosis (MS), some of the ways researchers are considering using stem cell therapy to treat MS, and the limitations of disease modifying treatments that stem cell therapy could help address. Advice will also be provided to clinicians whose patients are asking about stem cell therapy and when it will be available to them. This session focuses on the knowledge gaps around the risks and benefits of stem cell therapy and the ongoing research taking place to bring this therapeutic option from bench to bedside.
CME Eligibility End Date: 6/20/25